What do systematic reviews say?

Prevention of eclampsia: IV maintenance vs a serial IV bolus regimen

• Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 200 participants
  Very low

Prevention of eclampsia: IV maintenance vs a serial IV bolus regimen

It is very uncertain whether prevention of eclampsia: maintenance regimen by continuous infusion changes other neonatal morbidity: neonatal respiratory morbidity compared with a serial IV bolus regimen (very low certainty).

• Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
  RR 0.66 [0.29, 1.49]
  1 study · 197 participants
  Very low

Treatment of eclampsia: lower‐dose regimens vs standard‐dose strategies

It is very uncertain whether treatment of eclampsia: lower‐dose regimens changes recurrence of convulsions: lower dose versus Pritchard regimen compared with standard‐dose regimens (very low certainty).

• Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
  RR 1.69 [0.16, 17.84]
  1 study · 72 participants
  Very low

Treatment of eclampsia: lower‐dose regimens vs standard‐dose strategies

It is very uncertain whether treatment of eclampsia: lower‐dose regimens changes severe morbidity (renal failure): lower dose versus Pritchard regimen compared with standard‐dose regimens (very low certainty).

• Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
  RR 0.85 [0.06, 13.01]
  1 study · 72 participants
  Very low

Treatment of eclampsia: lower‐dose regimens vs standard‐dose strategies

The review found no eligible studies for this question.

• Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

It is very uncertain whether the intervention changes fetal, neonatal and infant death (very low certainty).

• Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour 2015 · Cochrane Headline outcomes only
  RR 0.43 [0.12, 1.56]
  1 study · 100 participants
  Very low

Intervention not reported

The intervention may leads to lower respiratory distress syndrome (low certainty).

• Different treatment regimens of magnesium sulphate for tocolysis in women in preterm labour 2015 · Cochrane Headline outcomes only
  RR 0.31 [0.11, 0.88]
  1 study · 100 participants
  Low